Let's Do That Again, Shall We? | GenomeWeb

Myriad Genetics was handed a win a few weeks ago when a federal appeals court ruled in the company's favor and upheld its BRCA gene patents. However, the court also struck down Myriad's methods patents. So now, both sides — Myriad and the plaintiffs represented by the ACLU — are asking the court to review its decision, though for different reasons, says Genomics Law Report's John Conley.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.